Roche cleared to launch early Alzheimer’s test in EU: company
Swiss pharmaceutical giant Roche said Tuesday that it had received clearance from health safety regulators to sell a…
Roche Launches New Respiratory Pathogen Test in CE Markets
The new Roche diagnostic test identifies 25 viruses and bacteria to help clinicians provide targeted care for high-risk…
Roche expands mass spectrometry menu to include steroid assays receiving CLIA ‘moderate complexity’ designation
Roche’s Ionify® steroid assays join its Vitamin D Total test as the latest mass spectrometry tests to receive…
Roche’s Mass Spectrometry Steroid Assays Receive FDA Moderate Complexity Designation
Roche announced that the Food and Drug Administration has categorized its Ionify steroid assays for mass spectrometry as…
Labcorp to Implement Roche’s Automated Mass Spectrometry Platform
Labcorp has entered into a commercial agreement with Roche to implement the cobas Mass Spec solution, marking the…
BioPorto’s Acute Kidney Injury Test Now Available to US Labs Through Roche Partnership
BioPorto A/S announced that its ProNephro AKI (NGAL) test for acute kidney injury is now commercially available to…
Roche Shares Alzheimer’s Drug and Diagnostic Advances at AAIC 2025
Roche is presenting new data from its Alzheimer’s development portfolio at the Alzheimer’s Association International Conference, taking place…
Roche Gains FDA Approval for Expanded HER2 Diagnostic Test Indications
The US Food and Drug Administration (FDA) has approved expanded indications for Roche’s Pathway anti-HER2/neu (4B5) Rabbit Monoclonal…